CDKN2A and neoplasm: An earlier study by Oshima suggested that mutations in SMAD4 were significantly associated with tumor size, lymphatic infiltration, and lymph node metastasis, whereas CDKN2A mutations were associated with lymphatic infiltration and extensive postoperative metastasis.